MiNK Therapeutics Inc (INKT)
0.98
+0.01
(+1.09%)
USD |
NASDAQ |
May 03, 16:00
0.9677
-0.01
(-1.26%)
After-Hours: 20:00
MiNK Therapeutics Cash from Investing (TTM): -0.0736M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.0736M |
September 30, 2023 | -0.2014M |
June 30, 2023 | -0.2382M |
March 31, 2023 | -0.2635M |
December 31, 2022 | -0.25M |
Date | Value |
---|---|
September 30, 2022 | -0.1219M |
June 30, 2022 | -0.174M |
March 31, 2022 | -0.2095M |
December 31, 2021 | -0.249M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.2635M
Minimum
Mar 2023
-0.0736M
Maximum
Dec 2023
-0.1979M
Average
-0.2095M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
Longeveron Inc | 8.186M |
RenovoRx Inc | 2.032M |
MSP Recovery Inc | 7.558M |
Etao International Co Ltd | -- |
Adlai Nortye Ltd | 27.30M |